Treatment satisfaction and limitations in haemophilia A, with a focus on factor VIII product storage conditions: patients’ perspectives and challenges

This publication has 21 references indexed in Scilit:

• Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project
  Blood, 2017
• Recognizing the need for personalization of haemophilia patient‐reported outcomes in the prophylaxis era
  Haemophilia, 2016
• Patient and parent preferences for characteristics of prophylactic treatment in hemophilia
  Patient Preference and Adherence, 2015
• Understanding patient preferences and willingness to pay for hemophilia therapies
  Patient Preference and Adherence, 2015
• Adherence to prophylaxis is associated with better outcomes in moderate and severe haemophilia: results of a patient survey
  Haemophilia, 2014
• Assessing patients' and caregivers' perspectives on stability of factor VIII products for haemophilia A: a web‐based study in the United States and Canada
  Haemophilia, 2014
• Advancing personalized care in hemophilia A: ten years’ experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method
  Biologics: Targets and Therapy, 2014
• Barriers and perceived limitations to early treatment of hemophilia
  Journal of Blood Medicine, 2013
• Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey
  Haemophilia, 2012
• Quantifying adherence to treatment and its relationship to quality of life in a well‐characterized haemophilia population
  Haemophilia, 2007